Tubectomy - Large Biopsy 3-6 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histology of excised tube.

₹666₹951

30% OFF

Tubectomy - Large Biopsy 3-6 cm: Comprehensive Medical Test Guide

Section 1: Why is it done?
- Test Description: Tubectomy with large tissue biopsy (3-6 cm specimen) is a surgical procedure involving the removal and histopathological examination of a segment of the fallopian tube. The procedure combines surgical resection with detailed microscopic analysis to identify pathological conditions.
- Primary Indications: Diagnosis of tubal pathology including ectopic pregnancy, tubal malignancy, chronic pelvic inflammatory disease, tubal tuberculosis, endometriosis affecting the tubes, and other structural abnormalities
- Therapeutic Indications: Permanent sterilization (tubectomy), management of ruptured ectopic pregnancy, treatment of infected or damaged fallopian tubes, and removal of suspicious tubal lesions
- Typical Timing: Performed during acute conditions (emergency tubectomy in ruptured ectopic pregnancy) or as planned procedures during gynecological surgery when pathology is suspected or sterilization is requested
Section 2: Normal Range
- Specimen Size Reference: 3-6 cm in length (standardized for adequate histological assessment)
- Normal Histological Findings: Normal tubal epithelium (single columnar epithelium), intact mucosa, normal smooth muscle layers, patent tubal lumen, absence of inflammation or malignancy
- Interpretation of Normal Result: Absence of malignancy, infection, tuberculosis, endometriosis, or significant structural abnormality; tube is anatomically normal with no evidence of chronic inflammation
- Negative Result Definition: No evidence of malignant cells, infectious agents (including MTB), or granulomatous lesions; histology is within normal limits or shows benign findings only
- Units of Measurement: Centimeters (cm) for specimen length; microscopic examination performed at 10x, 40x, and 100x magnification
Section 3: Interpretation
- Positive for Malignancy: Indicates presence of adenocarcinoma, carcinoma, or other malignant neoplasm; requires staging, adjuvant chemotherapy consideration, and multidisciplinary team management; poor prognostic indicator; necessitates further imaging and oncological consultation
- Positive for Tuberculosis (TB): Caseating granulomas with or without acid-fast bacilli (AFB); indicates genital tuberculosis; requires initiation of anti-TB therapy (typically 2-month intensive phase followed by 4-month continuation phase), contact tracing, and chest X-ray evaluation
- Positive for Chronic Inflammation/Infection: Lymphocytic infiltration, fibrosis, loss of normal mucosal pattern; indicates chronic pelvic inflammatory disease, previous infection, or chronic salpingitis; may result in tubal scarring and infertility
- Positive for Endometriosis: Presence of ectopic endometrial glands and stroma within tubal wall; confirms diagnosis; may indicate need for hormonal or surgical management; associated with infertility and pelvic pain
- Positive for Ectopic Pregnancy: Presence of trophoblastic tissue, chorionic villi, or gestational changes; confirms extrauterine implantation; appropriate intervention completed through tubectomy
- Factors Affecting Interpretation: Specimen adequacy, fixation quality, tissue sectioning technique, staining methods (H&E, special stains for AFB or organisms), previous treatments received, and associated clinical history
- Clinical Significance of Result Patterns: Pattern of findings guides treatment decisions, predicts reproductive outcomes, influences prognosis, and determines need for systemic therapy or additional imaging studies
Section 4: Associated Organs
- Primary Organ System: Female reproductive system; specifically the fallopian tubes (oviducts) which are part of the upper genital tract
- Associated Anatomical Structures: Uterus, ovaries, peritoneum, and pelvic vasculature; pathology may extend to involve adjacent organs
- Medical Conditions Associated with Abnormal Results:
- Ectopic pregnancy (tubal or interstitial), fallopian tube carcinoma, tubal tuberculosis, chronic pelvic inflammatory disease, tubal factor infertility, endometriosis of fallopian tubes, Asherman syndrome with tubal involvement, hydrosalpinx, tubal adhesions, and congenital tubal anomalies
- Diseases Diagnosed or Monitored: Genital tuberculosis (most common cause of infertility in developing countries), ovarian cancer with tubal involvement, peritoneal carcinomatosis, severe adhesive disease, and recurrent pregnancy loss due to tubal pathology
- Potential Complications of Abnormal Results: Infertility and diminished ovarian reserve, hemorrhage from ectopic pregnancy rupture, disseminated tuberculosis, peritonitis and sepsis, malignant spread to distant organs, chronic pelvic pain, recurrent infections, and requirement for additional surgical interventions
- Secondary Effects on Related Organs: Tubal pathology may affect ovarian function, uterine receptivity, and overall reproductive capacity; tuberculosis may involve endometrium and ovaries; malignancy may metastasize to peritoneum, omentum, and distant sites
Section 5: Follow-up Tests
- If Malignancy is Diagnosed: Staging CT/MRI abdomen-pelvis, chest imaging (CT or X-ray), CA-125 marker levels, gynecologic oncology consultation, possible hysterectomy and bilateral salpingo-oophorectomy, and consideration of chemotherapy protocols
- If Tuberculosis is Confirmed: Chest X-ray, tuberculin skin test (TST/Mantoux), sputum smear microscopy, anti-TB drug susceptibility testing, regular monitoring during 6-month therapy course, monitoring for treatment-related side effects (LFTs, audiometry), and endometrial biopsy if infertility is primary concern
- If Chronic Inflammation/PID is Found: Pelvic ultrasound follow-up, tubal factor infertility assessment, consider hysterosalpingography or laparoscopy to evaluate patency, partner screening and treatment for STIs, and evaluation for other pelvic pathology
- If Endometriosis is Confirmed: Repeat imaging (transvaginal ultrasound or MRI), hormonal therapy initiation (GnRH agonists, progestins, or combined oral contraceptives), pain management strategies, fertility counseling, and consideration of assisted reproductive technology if pregnancy desired
- Complementary Tests for Comprehensive Evaluation: Serum beta-hCG (if ectopic pregnancy), pelvic imaging (ultrasound/CT/MRI), tumor markers if malignancy suspected, microbiological cultures if infection identified, immunohistochemistry for tumor classification, and molecular testing for genetic markers when indicated
- Ongoing Monitoring Frequency: Malignancy: every 3 months for first 2 years, then every 6 months; TB: monthly during treatment; PID/Endometriosis: as clinically indicated; Normal results: no routine follow-up needed if asymptomatic
- Related Diagnostic Tests: Hysterosalpingography (HSG), laparoscopy with visualization, uterine artery Doppler, ovarian reserve assessment (AMH, FSH, AFC), diagnostic hysteroscopy, endometrial biopsy, and genetic testing if hereditary cancer suspected
Section 6: Fasting Required?
- Fasting Requirement: YES
- Fasting Duration: NPO (nothing by mouth) for minimum 6-8 hours before surgery; typically performed as morning procedure with overnight fasting (from midnight if surgery scheduled for early morning)
- Special Instructions: No food or beverages including water 6 hours prior to surgery; small sip of water allowed for essential medications only (as approved by anesthesiologist); clear fluids may be permitted up to 2 hours before if using regional anesthesia (confirm with surgical team)
- Medications to Avoid: Anticoagulants (warfarin, NOACs) - discontinue 3-5 days prior; aspirin and NSAIDs - stop 5-7 days before surgery; herbal supplements (especially those with anticoagulant properties like ginkgo, ginger, turmeric); however, routine cardiac medications may be taken with minimal water as directed; antidiabetic medications require specific adjustment per anesthesiologist
- Pre-operative Preparation Requirements: Bowel preparation (enema or laxative evening before may be requested); complete blood count, coagulation profile, renal function tests, and liver function tests must be normal; pregnancy test (urine or serum beta-hCG) to rule out unsuspected pregnancy; blood typing and cross-matching; clearance from anesthesia consultation; signed informed consent; removal of all jewelry, piercings, and prosthetics on day of surgery
- Procedure Type: Surgical procedure requiring general anesthesia, regional anesthesia, or spinal anesthesia (as per anesthesiologist's assessment) - not a simple blood test or outpatient imaging
- Post-operative Care: NPO status continued for 2-4 hours post-surgery until patient fully awake and gag reflex intact; gradual return to liquids then light diet as tolerated; pain management with prescribed analgesics; antibiotic prophylaxis or therapeutic course depending on findings; return to normal activities in 2-4 weeks with restrictions on heavy lifting and strenuous exercise

How our test process works!